BRPI0920248A2 - isolados e composicoes do virus torque teno(ttv) - Google Patents

isolados e composicoes do virus torque teno(ttv)

Info

Publication number
BRPI0920248A2
BRPI0920248A2 BRPI0920248A BRPI0920248A BRPI0920248A2 BR PI0920248 A2 BRPI0920248 A2 BR PI0920248A2 BR PI0920248 A BRPI0920248 A BR PI0920248A BR PI0920248 A BRPI0920248 A BR PI0920248A BR PI0920248 A2 BRPI0920248 A2 BR PI0920248A2
Authority
BR
Brazil
Prior art keywords
ttv
isolates
compositions
torque teno
teno virus
Prior art date
Application number
BRPI0920248A
Other languages
English (en)
Inventor
Donna Steuerwald Dunyak
Douglas Steven Pearce
Gregory Paul Nitzel
Jacqueline Gayle Marx
James Richard Thompson
Jay Gregory Calvert
Mira Ivanova Stoeva
Nancee Lois Oien
Robert Gerard Ankenbauer
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BRPI0920248A2 publication Critical patent/BRPI0920248A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0920248A 2008-10-16 2009-10-16 isolados e composicoes do virus torque teno(ttv) BRPI0920248A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19646808P 2008-10-16 2008-10-16
PCT/US2009/005662 WO2010044889A2 (en) 2008-10-16 2009-10-16 Torque teno virus (ttv) isolates and compositions

Publications (1)

Publication Number Publication Date
BRPI0920248A2 true BRPI0920248A2 (pt) 2016-01-05

Family

ID=42107116

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0920248A BRPI0920248A2 (pt) 2008-10-16 2009-10-16 isolados e composicoes do virus torque teno(ttv)
BR112012008946A BR112012008946A2 (pt) 2008-10-16 2010-04-16 sequência polinucletídica isolada , molécula pollinucleotídica de rna, vetor ou plasmídeo , célula hospedeira , vírus a ser expresso , vacina , polipetídeo e composição de vacina

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR112012008946A BR112012008946A2 (pt) 2008-10-16 2010-04-16 sequência polinucletídica isolada , molécula pollinucleotídica de rna, vetor ou plasmídeo , célula hospedeira , vírus a ser expresso , vacina , polipetídeo e composição de vacina

Country Status (11)

Country Link
US (3) US8969536B2 (pt)
EP (1) EP2356132A2 (pt)
JP (1) JP2012505653A (pt)
KR (3) KR20130054466A (pt)
CN (1) CN102256997A (pt)
AU (1) AU2009303845B2 (pt)
BR (2) BRPI0920248A2 (pt)
CA (1) CA2739469A1 (pt)
MX (1) MX2011004053A (pt)
RU (2) RU2502801C2 (pt)
WO (1) WO2010044889A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2076284A4 (en) * 2006-10-05 2010-03-31 Cerebus Biolog Inc METHODS OF TREATING, PREVENTING AND DIAGNOSING TTV INFECTION IN PORK
KR20130054466A (ko) 2008-10-16 2013-05-24 화이자 인코포레이티드 토크 테노 바이러스(ｔｔｖ) 분리물 및 조성물
US9249192B2 (en) 2009-08-21 2016-02-02 Virginia Tech Intellectual Properties, Inc. Infectious genomic DNA clone and serological profile of Torque teno sus virus 1 and 2
EP2467484A4 (en) * 2009-08-21 2013-06-12 Virginia Tech Intell Prop DIAGNOSIS OF TORQUE TENO VIRUS IN PIGS AND VACCINATE THEREOF
CA2775277A1 (en) * 2009-10-16 2011-04-21 Pfizer Inc. Infectious clones of torque teno virus
US8846388B2 (en) 2009-10-16 2014-09-30 Zoetis Llc Infectious clones of torque teno virus
EP2530170A1 (en) * 2011-05-31 2012-12-05 Intervet International BV Torque Teno virus diagnostics
WO2012168818A1 (en) * 2011-06-08 2012-12-13 Ah Usa 42 Llc Infectious clones of torque teno virus
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN102998453B (zh) * 2012-11-23 2014-10-08 广东海大畜牧兽医研究院有限公司 一种猪Ⅰ型细环病毒TTSuV1抗体间接ELISA诊断试剂盒及其制备方法
CN103205511B (zh) * 2013-04-27 2014-08-27 金陵科技学院 一种用于检测鸽细环病毒的引物对及其应用
WO2014182872A1 (en) 2013-05-08 2014-11-13 Protatek International, Inc. Vaccine for pcv2 and mycoplasma
CN106867972A (zh) * 2015-12-11 2017-06-20 上海交通大学医学院附属第九人民医院 小细环病毒及其获得方法和应用
CN108823231B (zh) * 2018-07-09 2022-05-31 荣俊 一种猪圆环病毒3型基因工程亚单位疫苗及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7004A (en) * 1850-01-08 Connecting ctjttees to shafts of boeing instetjments
US3137631A (en) * 1959-12-01 1964-06-16 Faberge Inc Encapsulation in natural products
US3959457A (en) * 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
JPS5186117A (en) 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
US4205060A (en) 1978-12-20 1980-05-27 Pennwalt Corporation Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
US4452747A (en) * 1982-03-22 1984-06-05 Klaus Gersonde Method of and arrangement for producing lipid vesicles
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4921706A (en) * 1984-11-20 1990-05-01 Massachusetts Institute Of Technology Unilamellar lipid vesicles and method for their formation
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
US5009956A (en) 1987-02-24 1991-04-23 Univ Minnesota Phospholipase A2-resistant liposomes
US4927637A (en) * 1989-01-17 1990-05-22 Liposome Technology, Inc. Liposome extrusion method
US4944948A (en) * 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
US5132117A (en) * 1990-01-11 1992-07-21 Temple University Aqueous core microcapsules and method for their preparation
DE69530227T2 (de) 1994-04-15 2004-04-01 Temple University Methode zum einkapseln mittels eines wässrigen lösungsmittels und mikrokapseln
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
AU4259299A (en) * 1998-05-13 1999-11-29 Innogenetics N.V. New sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
SE9901601D0 (sv) * 1999-05-04 1999-05-04 Tripep Ab Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus
CA2494193A1 (en) 2002-08-12 2004-02-19 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes
EP1543039B1 (en) 2002-08-12 2011-07-13 The Council Of The Queensland Institute Of Medical Research Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
WO2006084319A1 (en) 2005-02-08 2006-08-17 The Council Of The Queensland Institute Of Medical Research Immunogenic molecules
EP1856141A1 (en) 2005-02-25 2007-11-21 Pfizer Products Inc. N protein mutants of porcine reproductive and respiratory syndrome virus
EP2076284A4 (en) * 2006-10-05 2010-03-31 Cerebus Biolog Inc METHODS OF TREATING, PREVENTING AND DIAGNOSING TTV INFECTION IN PORK
KR20130054466A (ko) * 2008-10-16 2013-05-24 화이자 인코포레이티드 토크 테노 바이러스(ｔｔｖ) 분리물 및 조성물
RU2422536C1 (ru) * 2009-10-19 2011-06-27 Российская Федерация, от имени которой выступает Федеральное Агентство по науке и инновациям НАБОР СИНТЕТИЧЕСКИХ ОЛИГОНУКЛЕОТИДОВ ДЛЯ ВЫЯВЛЕНИЯ ДНК В КРОВИ И ДРУГИХ БИОМАТЕРИАЛАХ ВОЗБУДИТЕЛЯ ЛАТЕНТНОЙ ВИРУСНОЙ ИНФЕКЦИИ - ВИРУСА Torque teno virus СЕМЕЙСТВА Circoviridae МЕТОДОМ ПОЛИМЕРАЗНОЙ ЦЕПНОЙ РЕАКЦИИ

Also Published As

Publication number Publication date
WO2010044889A2 (en) 2010-04-22
US20140234355A1 (en) 2014-08-21
WO2010044889A3 (en) 2010-07-22
RU2013142007A (ru) 2015-03-27
EP2356132A2 (en) 2011-08-17
KR20130126755A (ko) 2013-11-20
AU2009303845A1 (en) 2010-04-22
US20110064758A1 (en) 2011-03-17
BR112012008946A2 (pt) 2016-08-16
CN102256997A (zh) 2011-11-23
US8969536B2 (en) 2015-03-03
US8921535B2 (en) 2014-12-30
KR101320192B1 (ko) 2013-10-30
RU2502801C2 (ru) 2013-12-27
JP2012505653A (ja) 2012-03-08
KR20110070911A (ko) 2011-06-24
KR20130054466A (ko) 2013-05-24
CA2739469A1 (en) 2010-04-22
US20110150913A1 (en) 2011-06-23
MX2011004053A (es) 2011-05-10
AU2009303845B2 (en) 2013-09-12
RU2011113442A (ru) 2012-11-27

Similar Documents

Publication Publication Date Title
BRPI0920248A2 (pt) isolados e composicoes do virus torque teno(ttv)
IL252154A0 (en) Antibodies against dr5, preparations containing them and their uses
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
IL222484A0 (en) Arginase inhibitor compounds, compositions comprising the same and uses thereof
BRPI0909770A2 (pt) Vacina, e, kit
DK3103478T3 (da) Stabiliserede fibronektin-domænesammensætninger, fremgangsmåder og anvendelser
BRPI0906473A2 (pt) Certas entidades químicas, composições e métodos
IL226383A0 (en) Antibodies against ccl20, preparations containing them and their uses
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0816350A2 (pt) Composições orais, produtos e métodos de uso
AP3031A (en) Avian influenza viruses, compositions, formulations, and methods
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
DK2245032T3 (da) Folater, sammensætninger og anvendelser deraf
EP2596017A4 (en) PROTECTION AGAINST CROSS-REACTIVE DISEASES AND METHODS AND COMPOSITIONS THEREFOR
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
IL209027A0 (en) Vaccine compositions and uses thereof
EP2376089A4 (en) CANCER VACCINE COMPOSITIONS AND THEIR METHODS OF USE
BRPI0810865A2 (pt) antígenos de tripanossoma, composições vacinais, e métodos relacionados
EP2245113A4 (en) PHOSPHORESCENT COMPOSITIONS, METHODS FOR PREPARING THE COMPOSITIONS, AND METHODS OF USING THE COMPOSITIONS
IL223405B (en) Phosphoplatins, preparations containing them and their uses
BRPI0919485A2 (pt) vacinas, antígenos, composições de plasmodium e métodos
GB201005625D0 (en) Immunogenic proteins and compositions
GB201103423D0 (en) Immunogenic proteins and compositions

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2372 DE 21-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25B Requested transfer of rights rejected

Owner name: PFIZER INC. (US)

B25E Requested change of name of applicant rejected

Owner name: PFIZER INC. (US)